Bleeding Disorders JANUARY 19, 2012 Erin M. Kwolek.

Slides:



Advertisements
Similar presentations
Coagulation: Review & Lab techniques
Advertisements

1 Tabuk University Faculty of Applied Medical Sciences Department Of Medical Lab. Technology 3 rd Year – Level 5 – AY
Hemorrhagic diseases. Lesions of the blood vessels Lesions of the blood vessels Abnormal platelets Abnormal platelets Abnormalities in the coagulation.
BLEEDING DISORDERS AN OVERVIEW WITH EMPHASIS ON EMERGENCIES.
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
Hemostatic System - general information Normal hemostatic system –vessel wall –circulating blood platelets –blood coagulation and fibrynolysis Platelets.
Hemostasis & Thrombosis: Platelet Disorders Beth A. Bouchard BIOC 212: Biochemistry of Human Disease Spring 2005.
DISORDERS OF PRIMARY HEMOSTASIS
HEMOSTASIS/THROMBOSIS II Congenital/Acquired Hemorrhagic Disorders & Their Treatment.
Bachelor of Chinese Medicine, The University of Hong Kong Bleeding disorders Dr. Edmond S. K. Ma Division of Haematology Department of Pathology The University.
Haemostasis Tiffany Shaw MBChB II Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.
Bleeding and coagulation disorders
Rare Bleeding Disorders Dr Joseph MAKDESSI TYR
Gatmaitan, Raymond Vincent Golpeo, Kirsten C.
Bleeding disorders. By Dr Abiodun Mark .A.
MLAB 1227: Coagulation Keri Brophy-Martinez
Hemophilia What is Hemophilia? Hemophilia is an inherited bleeding disorder in which there is a deficiency or lack of factor VIII or factor IX clotting.
Blood disorders.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
THROMBOCYTOPENIA - reduced platelet count -. First of all.. what are platelets? Platelets: tiny cells that circulate in the blood and whose function is.
Bleeding Disorders Dr. Farjah H.AlGahtani
Approach to Bleeding Disorders
APPROACH TO BLEEDING DISORDERS. History of Bleeding Spontaneous vs. trauma/surgery-induced Ecchymoses without known trauma Medications or nutritional.
Mrs. M. Jansen van Vuuren Universitas Academic Hospital Bloemfontein.
Disseminated Intravascular Coagulation. XIIa Coagulation cascade IIa Intrinsic system (surface contact ) XII XI XIa Tissue factor IX IXa VIIa VII VIIIVIIIa.
The hemophilias A and B X-linked hereditary blood clotting disorders due to deficiency of factor VIII (hemophilia A) or factor IX (hemophilia B) Identical.
Hemophilia  Definition: rare bleeding disorders due to inherited deficiencies in co-agulation factors  Types: 1. Haemophilia A (Classic) Factor VIII.
1 Alterations of Hematologic Function in Children Chapter 28.
February 4 th, The Child With Pain Single Joint Involvement Multiple Joint Involvement With Fever Septic arthritis/Osteomyelitis Sympathetic arthritis.
Bleeding and Kristine Krafts, M.D. Thrombotic Disorders.
Inherited bleeding disorder of primary hemostasis.
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
The Basics of Hemophilia. Hemostatic System Blood vessels Platelets Plasma coagulation system Proteolytic or Fibrinolytic system.
Von Willebrand’s Disease. vWD Family of bleeding disorders Family of bleeding disorders Caused by a deficiency or an abnormality of von Willebrand Factor.
INHERITED DISORDERS OF COAGULATION von Willebrand Disease 1.
Approach to Petechiae And Purpura Supervised by:P.H.D.Khaled Khanji Presented by: Salah Eddin Younes Aleppo university hospital medical symposium.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 26 Disorders of Hemostasis.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Approach to the Bleeding Child. Evaluation  History Current Bleeding Medical Family  Physical exam  Selected laboratory investigations.
Coagulation tests CBC- complete blood count
Abnormal bleeding in children J Kiwanuka. GENERAL INTRODUCTION.
Chapter 23. Bleeding disorders associated with coagulopathy
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Haemostasis describes the normal process of blood clotting. It takes place via a series of complex, tightly regulated interactions involving cellular.
Congenital bleeding disorders
Bleeding disorders due to vascular & platelets abnormalities
Approach To Bleeding Disorders In Neonates
Multiple choice questions
Hemophilia 2009.
Chapter 18 Disorders of Hemostasis
Coagulation cascade:.
Understanding ICD-9-CM Coding
Bleeding disorders Dr. Feras FARARJEH.
Platelets disorders.
Diagnosis Approach of Bleeding in Children ________________________________ Ketut Ariawati Hematologi Onkologi RSUP Sanglah Denpasar.
Constituents of the blood: Platelets and plasma
Bleeding and Thrombotic Disorders.
Von Willebrand Disease
Dr-Majid Qanavat Ped. Hematologist oncologist Isfahan university -1396
Congenital bleeding disorders
The Fascinating World of Haemostasis and Thrombosis
Intrinsic pathway Formation of prothombin activator is the central event in the clotting pathway For its formation the pathway that is initiated by.
Bleeding and Thrombotic Disorders Kristine Krafts, M.D.
Hemophilia By: Renee Marie Alta.
Bleeding disorders Dr. Feras FARARJEH.
The child with hematological dysfunction
Dr. Ahmed Hassaneen Coagulation disorders.
Hemostasis and Coagulation
Presentation transcript:

Bleeding Disorders JANUARY 19, 2012 Erin M. Kwolek

3 important questions… Is the bleeding significant? Is the bleeding likely related to an underlying health problem or to medication/chemical ingestion? Is there a family history of a bleeding disorder?

Important historical information The nature of bruising Site of bleeding Bleeding with trauma Duration of bleeding tendency General health Drug and chemical ingestion Family history of bleeding

Bleeding/Bruising Platelets Vascular System Coagulation Proteins

Bleeding/Bruising Platelets Vascular System Coagulation Proteins Congenital Acquired

hemophilia 1.Hemophilia 2.Porphyria 3.HIV/AIDS 4.Smallpox 5.Plague 6.Cholera 7.Tuberculosis 8.Syphillis 9.Influenza 10.Malaria 11.Yellow Fever 12.Irish Potato Blight

Hemophilia A history Talmud – babies did not have to be circumcised if two brothers had died from the procedure 1803 – “hemorrhagic disposition existing in certain families” hemophilia

Hemophilia severity Factor VII or IX levelSeverityType of bleeding <0.01 IU/mLSevereSpontaneous, minimal trauma, young age 0.01 – 0.05 IU/mL (1-5%) ModerateWith trauma or surgery, can be spontaneous 0.06 – 0.40 IU/mL (6-40%) MildOnly with trauma or surgery, can present in adulthood

Hemophilia A Factor VIII 1:10,000 Classic hemophilia, Royal disease

Hemophilia B Factor iX 1:60,000 Christmas disease

Hemophilia treatment Replace missing clotting factors Education and lifestyle On demand vs. Prophylactic

Clotting factors in canada ProductIntroduction in Canada Fresh whole blood1947 Cryoprecipitate (Factor VIII)1965 Factor VIII (lyophilized, unheated)1968 Factor VIII (lyophilized, dry heat-treated) Factor IX (lyophilized, dry heat-treated) 1985 Factor VIII (viral inactivation: vapour heat, solvent detergent) 1987 High purity factor VIII (monoclonal antibody purified) Purity factor IX GE recombinant factor VIII concentrate GE recombinant factor IX concentrate

Von willebrand Von Willebrand factor is made and stored in endothelial cells Anchors platelets to subendothelium Factor is made up of protein multimers – the more repeating units the “stickier” (more effective) the factor is Stabilizes factor VIII in plasma

VW Dx severity TYPE 1 – partial quantitative deficiency 80% of people with VW Dx have type 180% of people with VW Dx have type 1 TYPE 2 – qualitative defect TYPE 3 – virtually complete quantitative deficiency Very rareVery rare First type describedFirst type described Variable expressivity and incomplete penetrance

Von willebrand treatment Exogenous - Desmopressin ~3x increase in plasma VWF and factor VIII~3x increase in plasma VWF and factor VIII Not useful if qualitative abnormality (type 2)Not useful if qualitative abnormality (type 2) Not useful if complete deficiency (type 3)Not useful if complete deficiency (type 3) Endogenous – factors Plasma derived VWF concentrate – contains VWF and factor VIIIPlasma derived VWF concentrate – contains VWF and factor VIII

Hemophilia AHemophilia BVon Willebrand Inheritance X-linked autosomal dominant Deficiency Factor VIIIFactor IVVW factor, VIIIC Bleeding sites muscle, joint mucous membranes, skin, menstrual PT normal PTT prolonged prolonged or normal Bleeding time normal prolonged or normal Factor VIII activity lownormallow or normal VW factor antigen normal low VW factor activity normal low Factor IX normallownormal Platelet aggregation normal

Hemophilia AHemophilia BVon Willebrand Inheritance X-linked autosomal dominant Deficiency Factor VIIIFactor IVVW factor, VIIIC Bleeding sites muscle, joint mucous membranes, skin, menstrual PT normal PTT prolonged prolonged or normal Bleeding time normal prolonged or normal Factor VIII activity lownormallow or normal VW factor antigen normal low VW factor activity normal low Factor IX normallownormal Platelet aggregation normal

Hemorrhagic disease of the newborn Normal PTT, prolonged PT VKDB – early, classic, late Prophylactic Vitamin K Intracranial VKDB Vitamin K Deficiency Child/AdultNewborn

Bleeding/Bruising Platelets Thrombocytopenia Quantitative Defect Disordered Function Qualitative Defect Congenital Acquired Vascular System Coagulation Proteins

< 10 severe mucosal/internal bleeding< 10 severe mucosal/internal bleeding petechiae, purpura, ecchymoses10-30 petechiae, purpura, ecchymoses easy bruising30-50 easy bruising > 50 asymptomatic> 50 asymptomatic

Thrombocytopenia Decreased production Increased destruction Abnormal sequestration Normal value – x 10 9 /L Lifespan 7-10d

Thrombocytopenia decreased production Toxins/drugs/alcohol Aplastic anemia Intrinsic bone marrow Displacement Nutritional deficiency Hereditary thrombocytopenias

Thrombocytopenia Increased destruction Auto Immune - ITP

Thrombocytopenia non-immune DICTTPVasculitisHELLP

DIC Activation of coagulation – failure of homeostasis with bleeding and/or thrombosis; consumption of clotting factors and platelets InfectionTrauma Abnormal endothelial surface Cancer Obstetrical complications

Thrombocytopenia Increased sequestration Splenomegaly

Platelet dysfunction Congenital causes are rare! Glanzmann thrombastheniaGlanzmann thrombasthenia Glycoprotein IIb/IIIaGlycoprotein IIb/IIIa Bernard-Soulier syndromeBernard-Soulier syndrome Glycoprotein Ib/IX/VGlycoprotein Ib/IX/VAcquired DrugsDrugs Renal diseaseRenal disease Bone marrow disordersBone marrow disorders

3 important questions… Is the bleeding significant? Is the bleeding likely related to an underlying health problem or to medication/chemical ingestion? Is there a family history of a bleeding disorder?